MINUTES OF MEETING - March 6-7 
2 
Other National Institutes of Health staff present were : 
Dr. Edward Applebaum, NCI; Dr. Stanley Barban, NIAID; Dr. W. Emmett Barkley, 
OKS; Mrs. Betty Butler, NIAID; Dr. Irving Delappe, NIAID; Dr. John Irwin, 
ORS; Dr. Micah I. Krichevsky, NIDR; Dr. Richard Krause, NIAID; Mr. Charles 
Leasure, NIAID; Dr. Malcolm Martin, NIAID; Dr. Elizabeth Milewski, NIAID; 
Dr. Stanley Nagle, NIAID; Dr. John Nutter, NIAID; Dr. Joseph Perpich, OD; 
Mr. Richard Riseberg, OGC; Dr. Wallace Rowe, NIAID; Dr. Bernard Talbot, OD; 
and Dr. Rudolf Wanner, ORS. 
Others in attendance for all or part of the meeting were : 
Dr. Harvey C. Aaron, Occupational Safety and Health Administration; Dr. Queta 
Bond, National Academy of Sciences; Dr. K. C. Bora, Health & Welfare, Canada; 
Dr. Peter G. Bostock, New Brunswick Scientific Co., Inc.; Dr, J. Paul Burnett, 
Eli Lilly & Company; Dr. William Can, Jack Raymond & Company; Mr. Jeffrey 
Christy, Blue Sheet; Dr. Howard Eddy, Science Council of Canada; Dr. Russel K. 
Enns, Alpha Therapeutic Corp.; Dr. Stanley Falkow, University of Washington; 
Dr. Mark Finkelstein, Sobering Corporation; Dr. Zsolt Harsanyi, Office of Tech- 
nology Assessment; Ms. Linda Haverfield, Friends of the Earth; Dr. Paul Hung, 
Abbott Research Laboratories; Dr. Evelyn Hurlburt, Johns Hopkins School of 
Hygiene; Dr. I. S. Johnson, Eli Lilly & Company; Dr. Attila I. Kadar, Food and 
Drug Administration; Dr. Geoffrey Karny, Office of Technology Assessment; 
Dr. Charles C. Kimble, Food and Drug Administration; Dr. David W. Krogmann, 
U. S. Department of Agriculture; Dr. Paul Leibowitz, Schering Corporation; 
Dr. M. A. Levine, Environmental Protection Agency; Dr. F. R. Marks, University 
of California, San Francisco; Ms. Carmine Masucci, New Brunswick Scientific Co., 
Inc.; Mr. Bing Miller, New Brunswick Scientific Co., Inc.; Ms. Julie Miller, 
Science News; Dr. Henry I. Miller, Food and Drug Administration; Mr. J. S. 
Narrim, Virginia, Office of Governor; Dr. DeLill Nasser, National Science 
Foundation; Mr. Seth Pauker, National Institute for Occupational Safety and 
Health; Dr. James D. Punch, Upjohn Co.; Dr. Anthony Robbins, National Institute 
for Occupational Safety and Health; Dr. Michael Ross, Genentech, Inc.; Dr. Brian 
Sheehan, Genentech, Inc.; Dr. Richard Silver, Food and Drug Administration; 
Dr. J. R. Swarz, Staff, United States Senate; Dr. Vicki Weisfeld, Institute of 
Medicine; Dr. Susan Wright, University of Michigan; and Dr. W. P. Young, Eli 
Lilly & Company. 
[ 37 ] 
